Patient compliance and persistence with antihyperglycemic drug regimens: evaluation of a medicaid patient population with type 2 diabetes mellitus.
about
Adherence to oral hypoglycemic agents in Hawaii.Evaluation of the chronic disease management program for appropriateness of medication adherence and persistence in hypertension and type-2 diabetes patients in Korea.Current therapeutic options in type 2 diabetes mellitus: a practical approachInsulin use and persistence in patients with type 2 diabetes adding mealtime insulin to a basal regimen: a retrospective database analysis.A retrospective database analysis of insulin use patterns in insulin-naïve patients with type 2 diabetes initiating basal insulin or mixtures.Comparisons of persistence and durability among three oral antidiabetic therapies using electronic prescription-fill data: the impact of adherence requirements and stockpiling.How to use pharmacy claims data to measure patient nonadherence? The example of oral diabetics in therapy of type 2 diabetes mellitus.Factors associated with adherence to oral antihyperglycemic monotherapy in patients with type 2 diabetesMeasuring Persistence to Oral Hypoglycemic Agents in Type 2 Diabetic VeteransAdherence to oral anti-diabetic drugs among patients attending a Ghanaian teaching hospital.Adherence to oral therapy for type 2 diabetes: opportunities for enhancing glycemic control.Type D Personality Predicts Poor Medication Adherence in Chinese Patients with Type 2 Diabetes Mellitus: A Six-Month Follow-Up Study.Adherence to insulin treatment in insulin-naïve type 2 diabetic patients initiated on different insulin regimens.Does prior authorization of sibutramine improve medication compliance or weight loss?Does medication adherence following a copayment increase differ by disease burden?Effect of metformin monotherapy on cardiovascular diseases and mortality: a retrospective cohort study on Chinese type 2 diabetes mellitus patients.Provider-patient adherence dialogue in HIV care: results of a multisite study.Impact of telephonic interviews on persistence and daily adherence to insulin treatment in insulin-naïve type 2 diabetes patients: dropout studyMeasuring drug exposure: concordance between defined daily dose and days' supply depended on drug classDevelopment of a new diabetes medication self-efficacy scale and its association with both reported problems in using diabetes medications and self-reported adherenceMedication taking and diabetes: a systematic review of the literature.Association between payments from manufacturers of pharmaceuticals to physicians and regional prescribing: cross sectional ecological study.Effect of prescription copayments on adherence and treatment failure with oral antidiabetic medications.The dipeptidyl peptidase (DPP)-4 inhibitors for type 2 diabetes mellitus in challenging patient groups.Fixed-dose combinations for treatment of type 2 diabetes mellitus.Individualized treatment of type 2 diabetes mellitus using noninsulin agents: clinical considerations for the primary care physician.Medication adherence in patients with diabetes and dyslipidemia: associated factors and strategies for improvement.Early combination therapy for the treatment of type 2 diabetes mellitus: systematic review and meta-analysis.Use of oral combination therapy for type 2 diabetes in primary care: Meeting individualized patient goals.Impact of depression and anxiety disorders on adherence to oral hypoglycemics in older adults with diabetes mellitus in Canada.Retrospective Study on the Impact of Adherence in Achieving Glycemic Goals in Type 2 Diabetes Mellitus Patients Receiving Canagliflozin.Predictors of non-adherence to pharmacotherapy in patients with type 2 diabetes.Impact of hypoglycemic events and HbA1c level on sulfonylurea discontinuation and down-titration.Risk factors associated with treatment discontinuation and down-titration in type 2 diabetes patients treated with sulfonylureas.Missed doses of oral antihyperglycemic medications in US adults with type 2 diabetes mellitus: prevalence and self-reported reasons.New perspectives in type 2 diabetes, cardiovascular risk, and treatment goals.Strategies to improve adherence with medications in chronic, 'silent' diseases representing high cardiovascular risk.Use of antidepressants and the risk of type 2 diabetes mellitus: a nested case-control study.Combined bedtime insulin--daytime sulphonylurea regimen compared with two different daily insulin regimens in type 2 diabetes: effects on HbA1c and hypoglycaemia rate--a randomised trial.Greater reductions in A1C in type 2 diabetic patients new to therapy with glyburide/metformin tablets as compared to glyburide co-administered with metformin.
P2860
Q25257800-977F19C4-1E64-4502-9F84-0CCD487D096AQ33621412-E4F7643C-7E55-4BCE-8163-123B32C1565AQ33723387-7AA50ACD-D70A-4163-921C-EED2DF9F6DF8Q33791319-E2E6C5DF-A390-41AB-B317-3C0A6CCE80D7Q33966104-3E944EB4-4B89-42BE-BC34-180B347FCC0CQ34065562-9F2966E9-796E-41C9-BD0A-6418656FBEA8Q34344393-95CE7872-63E6-4E1C-BB68-30C79CA5B461Q35043805-86E6C008-1E56-4CE0-8CEE-0B646D58C933Q35113964-AE7E93E1-53CE-4933-AF9B-9D90D3269DADQ35257188-7797D90D-98ED-48AD-AB42-050F08B16DBCQ35685331-AB45EAE7-BF12-4ED4-B063-8E1AF880E47EQ35928514-5D5505D4-9E96-4BAD-9665-761B32EBB91DQ36015855-92C5E316-103B-44A9-B0B4-8A41FFDE915AQ36068014-EA49FE6F-0CE9-4258-BE3C-A889E13AA6F3Q36085521-E0B2F634-E9D5-41D0-9831-0DE3B6280872Q36144000-EFB77F99-93D1-4D0F-ADA7-3C8C02261CF6Q36889087-351A6C15-0707-4BCB-837E-E51063F10D13Q36924493-90DDB8B5-1722-460D-AFDD-2DBA7A66D004Q36938525-23C67C18-1D6C-48A3-9114-F2BF131159B8Q37007304-CC6A8A3A-F9C2-4225-96B4-B353A0922214Q37023520-50B6582B-1A6E-4175-A9A3-CD90726FEDC7Q37185115-2F628F44-5AC9-48D0-95D9-A443185E469BQ37313678-A95A17E9-0120-4FF9-8C1A-34599179222DQ37502682-362D34B5-D0C3-4480-B3A5-60E637BB2DB4Q37978206-61FAB4ED-0362-4798-90C8-A71D76E01082Q38036773-D6F9D58C-DC90-425F-ABCD-330A11DC1C54Q38140755-E9FEDD52-35FE-44A4-AF4A-4294C3AAF9E7Q38160887-B040C221-6156-4CF3-8050-579E0DBE0FF4Q38599975-7E18244C-3AAE-473D-854D-0BE8AA5C9FB2Q38626703-77153245-350B-49D4-B3F3-E033A345AFCFQ38934278-E79D9069-BCBF-4DD8-9599-1E3B46E9B3F1Q39196860-781C20BB-4C17-4216-9C54-63228B7C12DBQ40681506-54402570-DB6B-4EA9-BE06-5693AF03E1F7Q40756010-4014EE60-188C-405C-8337-C6D431548F2CQ40769766-9027C281-CDF8-471F-9DFB-879EF0A1CA8EQ42171251-BD30D474-2188-4C5E-8093-7165B15878CEQ43042777-BA82462E-8C21-4D5A-9D70-7ADC14C07780Q43858341-12CD274D-21BC-48C7-804A-EBCE8ACB6B07Q44389362-2F030138-3C19-4CE0-9B9C-75D7585FA688Q44655649-08EFDA40-6A03-4993-B05C-398090025979
P2860
Patient compliance and persistence with antihyperglycemic drug regimens: evaluation of a medicaid patient population with type 2 diabetes mellitus.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Patient compliance and persist ...... with type 2 diabetes mellitus.
@en
Patient compliance and persist ...... with type 2 diabetes mellitus.
@nl
type
label
Patient compliance and persist ...... with type 2 diabetes mellitus.
@en
Patient compliance and persist ...... with type 2 diabetes mellitus.
@nl
prefLabel
Patient compliance and persist ...... with type 2 diabetes mellitus.
@en
Patient compliance and persist ...... with type 2 diabetes mellitus.
@nl
P2093
P1476
Patient compliance and persist ...... with type 2 diabetes mellitus.
@en
P2093
P304
P356
10.1016/S0149-2918(01)80110-7
P577
2001-08-01T00:00:00Z